Great Lakes Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.38M	Sell	241,827 -71,709	-23%	-$1.71M	0.04%	211
2025 Q4	$8.37M	Sell	313,536 -141,254	-31%	-$3.38M	0.07%	171
2025 Q3	$9.71M	Sell	454,790 -333,245	-42%	-$7.88M	0.08%	168
2025 Q2	$17M	Buy	788,035 +175,355	+29%	+$3.26M	0.14%	137
2025 Q1	$10.2M	Buy	612,680 +72,667	+13%	+$1.32M	0.09%	192
2024 Q4	$9.91M	Buy	+540,013	New	+$8.72M	0.08%	203
2021 Q2	–	Sell	-482,666	Closed	-$12.5M	–	703
2021 Q1	$12.5M	Buy	482,666 +32,152	+7%	+$1.42M	0.2%	157
2020 Q4	$24.1M	Buy	+450,514	New	+$22.4M	0.44%	66
2018 Q4	–	Sell	-202,452	Closed	-$4.2M	–	558
2018 Q3	$4.2M	Sell	202,452 -11,521	-5%	-$181K	0.09%	219
2018 Q2	$3.27M	Buy	+213,973	New	+$3.82M	0.08%	252